NCT04498923View on ClinicalTrials.gov

Duration of Blockade of Peripheral Nerves With Bupivacaine Depending of the Adjuvants

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

April 5, 2022

Study Completion Date

April 5, 2022

Conditions

Postoperative PainPeripheral NeuropathyFractures of the Upper LimbFracture of the Lower Limb (Except Hip), Initial EncounterIntraoperative HypotensionIntraoperative HypertensionPain SyndromeAnesthesiaAnesthesia, LocalLocal Anesthetic Systemic Toxicity

Interventions

DRUG

Bupivacaine, dexamethasone, epinephrine

Bupivacaine 75 mg, dexamethasone 4 mg, epinephrine 0,18 mg

Trial Locations (1)

33000

Rivne Oblast State Hospital, Rivne

All Listed Sponsors

lead

Lviv National Medical University

OTHER

NCT04498923 - Duration of Blockade of Peripheral Nerves With Bupivacaine Depending of the Adjuvants | Biotech Hunter | Biotech Hunter